|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL STUDY |
1 Section for Endocrinology, Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway2 Institute of Medicine, University of Bergen, N-5007 Bergen, Norway3 St. Olavs University Hospital, N-7030 Trondheim, Norway4 Institute of Clinical Medicine, University of Trømsø, N-9037 Tromsø, Norway5 Department of Medicine, University Hospital of North Norway, 9038 Trømsø, Norway6 NKS Olaviken Hospital for Old Age Psychiatry, N-5009 Bergen, Norway7 Rikshospitalet-Radiumhospitalet University Hospital, N-0310 Oslo, Norway8 University of Oslo, Oslo, Norway9 Ullevål University Hospital, N-0450 Oslo, Norway10 Aker University Hospital, N-0514 Oslo, Norway11 Østfold Hospital, N-1606 Fredrikstad, Norway
(Correspondence should be addressed to M M Erichsen; Email: mmer{at}helse-bergen.no)
Context: Primary adrenal insufficiency (Addison's disease) is a rare autoimmune disease. Until recently, life expectancy in Addison's disease patients was considered normal.
Objective: To determine the mortality rate in Addison's disease patients.
Design and methods: i) Patients registered with Addison's disease in Norway during 1943–2005 were identified through search in hospital diagnosis registries. Scrutiny of the medical records provided diagnostic accuracy and age at diagnosis. ii) The patients who had died were identified from the National Directory of Residents. iii) Background mortality data were obtained from Statistics Norway, and standard mortality rate (SMR) calculated. iv) Death diagnoses were obtained from the Norwegian Death Cause Registry.
Results: Totally 811 patients with Addison's disease were identified, of whom 147 were deceased. Overall SMR was 1.15 (95% confidence intervals (CI) 0.96–1.35), similar in females (1.18 (0.92–1.44)) and males (1.10 (0.80–1.39)). Patients diagnosed before the age of 40 had significantly elevated SMR at 1.50 (95% CI 1.09–2.01), most pronounced in males (2.03 (1.19–2.86)). Acute adrenal failure was a major cause of death; infection and sudden death were more common than in the general population. The mean ages at death for females (75.7 years) and males (64.8 years) were 3.2 and 11.2 years less than the estimated life expectancy.
Conclusion: Addison's disease is still a potentially lethal condition, with excess mortality in acute adrenal failure, infection, and sudden death in patients diagnosed at young age. Otherwise, the prognosis is excellent for patients with Addison's disease.
This article has been cited by other articles:
![]() |
K. White and W. Arlt Adrenal crisis in treated Addison's disease: a predictable but under-managed event Eur. J. Endocrinol., January 1, 2010; 162(1): 115 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Erichsen, K. Lovas, B. Skinningsrud, A. B. Wolff, D. E. Undlien, J. Svartberg, K. J. Fougner, T. J. Berg, J. Bollerslev, B. Mella, et al. Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry J. Clin. Endocrinol. Metab., December 1, 2009; 94(12): 4882 - 4890. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Arlt The Approach to the Adult with Newly Diagnosed Adrenal Insufficiency J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1059 - 1067. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |